Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2016-A00013-48 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this pilot study is to make a first assessment of the discriminating ability of a dosage of S100B protein for differential diagnosis between primary headaches and secondary headaches.
For this, the investigators will compare serum S100B protein between two groups of headache patients presenting at the emergency department: 1 group of primary headache patients and 1 group of secondary headache patients.
If the difference between the two groups proves potentially discriminating, the investigators will seek to determine the discriminating ability of the S100B protein by calculating the area under the ROC curve.
The reference diagnostic will be set at one month across the entire clinical picture and imaging by an expert committee composed of a neurologist, a radiologist and an emergency physician.
The secondary objectives of this study are:
A. To seek an association between S100B protein levels and the onset of pain depending on whether it is more or less than 3 hours.
B. To assess the association between S100B protein levels and mortality at day 28.
C. To evaluate the association between S100B protein levels and hospital care: average length of stay in the emergency department, lumbar puncture, brain imaging, average length of hospital stay.
D. To evaluate the prognostic value of determination of S100B protein on the occurrence of a secondary headache at 1 month.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| The study population | Experimental | The study population consists of consecutive headache patients (visual analogue scale > 3) presenting at the emergency department of the Nîmes University Hospital |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Plasma S100B levels at inclusion | Biological | Patients will have blood drawn to measure plasma S100B levels at inclusion. |
|
| Measure | Description | Time Frame |
|---|---|---|
| S100B protein level (ng/ml) | Day 0 | |
| The presence/absence of a clinically significant anomaly on the MRI scan | Days 2-4 | |
| Final diagnostic as established by an expert committee | The diagnostic posed is either "primary headache" or "secondary headache" | Month 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Mortality (yes/no) | "Mortality" refers to whether or not the subject is still alive. | Month 1 |
| Length of stay in the emergency department (days) | Month 1 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Romain Genre Grandpierre, MD | Centre Hospitalier Universitaire de NÄ«mes | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHRU de Nîmes - Hôpital Universitaire Carémeau | Nîmes | 30029 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37001377 | Result | Grau-Mercier L, Grandpierre RG, Alonso S, Savey A, Le Floch A, de Oliveira F, Masia T, Jory N, Coisy F, Claret PG. S100B serum level: A relevant biomarker for the management of non-traumatic headaches in emergency care? Am J Emerg Med. 2023 Jun;68:132-137. doi: 10.1016/j.ajem.2023.03.036. Epub 2023 Mar 25. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006261 | Headache |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D008279 | Magnetic Resonance Imaging |
| ID | Term |
|---|---|
| D014054 | Tomography |
| D003952 | Diagnostic Imaging |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Magnetic resonance imaging | Device | If not performed under emergency conditions, patients will have an MRI on days 2-4. |
|
| Length of stay in the hospital (days) | Month 1 |
| White blood cell count in cerebral spinal fluid | Month 1 |
| Red blood cell count in cerebral spinal fluid | Month 1 |
| Cerebral spinal fluid glucose level | Month 1 |
| Cerebral spinal fluid protein level | Month 1 |
| Cerebral spinal fluid chloride level | Month 1 |
| Presence/absence of enterovirus in cerebral spinal fluid | Based on qualitative result from ELISA laboratory exam. | Month 1 |
| Presence/absence of herpes virus in cerebral spinal fluid | Based on qualitative result from ELISA laboratory exam. | Month 1 |
| Presence/absence of cerebral imaging indicating an ischemic or hemorrhagic stroke, subarachnoid hemorrhage, an expansive process, cerebral trombophlebitis cerebral or other abnormalities suggestive of a secondary cause of headache. | Month 1 |
| Secondary headache onset: yes/no | Was there secondary headache onset by month 1? | Month 1 |